Product Images Azacitidine For

This appears to be a survival analysis plot comparing the efficacy of two different treatments (AZA and CCR) in terms of proportion of patients surviving over time (measured in months). The plot shows data for two groups, with AZA in blue and CCR in red, and indicates that AZA is associated with a higher proportion of surviving patients compared to CCR. The plot also gives some numerical values such as the total number of patients at risk, the log-rank p-value, hazard ratio and confidence interval along with the number of deaths in each group.*

This sterile single-dose vial contains 100 mg of Azacitidine and 100 mg Mannitol for intravenous and subcutaneous use only. It is packaged with the prescribing information including dosing and administration procedures. The unused portion should be discarded and the vial should be kept out of reach of children. It should be stored at 25°C (77°F) with excursions permitted to 15°C-30°C (59°-86°F). It is manufactured by Shilpa Medicare Limited in India and distributed by Cipla USA, Inc. NDC 69097-805-40 Rx Only. Lot number 4500641, 99326220, 80540 with code TSIDRUGS/1/2013.*

This is a description of a medication called Azactidine. It is available in a single-dose vial that contains 100mg of Azactidine and 100mg of mannil. This medication is for use via injection only, either subcutaneously or intravenously. It is important to follow the prescribing information for dosing and administration, and to discard any unused portions of the single-dose vial. The medication should be stored at a temperature between 21-25°C, with excursions allowed between 15-30°C, per USP controlled temperature guidelines.*